WallachBeth Capital Downgrades Impax Laboratories (IPXL) to Hold
- S&P 500, Nasdaq set records as tech, banks lead
- Texas Instruments (TXN) Tops Q4 EPS by 20c, Issues Solid Q1 Outlook
- Intuitive Surgical (ISRG) Tops Q4 EPS by 10c; $2B Accelerated Share Repurchase
- Seagate Technology (STX) Tops Q2 EPS by 30c
- After-Hours Stock Movers 01/24: (BOBE) (STX) (WDC) Higher; (NEWT) (MRCY) (CA) Lower (more...)
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
WallachBeth Capital downgraded Impax Laboratories (NASDAQ: IPXL) from Buy to Hold.
Shares of Impax Laboratories closed at $15.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. reaches settlement with Endo on pay-for-delay charges
- Mercury Computer (MRCY) PT Raised to $30 at Jefferies Following 2Q Report
- Avondale Partners Downgrades Cross Country Healthcare (CCRN) to Market Perform
Create E-mail Alert Related CategoriesDowngrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!